Pharmacy and Self-Report Adherence Measures to Predict Virological Outcomes for Patients on Free Antiretroviral Therapy in Tamil Nadu, India

[1]  N. Nischal,et al.  Factors Influencing Adherence to ART , 2013, Journal of the International Association of Providers of AIDS Care.

[2]  M. Ekstrand,et al.  Reasons for and correlates of antiretroviral treatment interruptions in a cohort of patients from public and private clinics in southern India , 2012, AIDS care.

[3]  R. Paranjape,et al.  Initial virologic response and HIV drug resistance among HIV-infected individuals initiating first-line antiretroviral therapy at 2 clinics in Chennai and Mumbai, India. , 2012, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[4]  M. Ekstrand,et al.  High rates of adherence and treatment success in a public and public-private HIV clinic in India: potential benefits of standardized national care delivery systems , 2011, BMC health services research.

[5]  G. Kibiki,et al.  Electronic monitoring of treatment adherence and validation of alternative adherence measures in tuberculosis patients: a pilot study. , 2011, Bulletin of the World Health Organization.

[6]  M. Ekstrand,et al.  Suboptimal adherence associated with virological failure and resistance mutations to first-line highly active antiretroviral therapy (HAART) in Bangalore, India. , 2011, International health.

[7]  S. Lewin,et al.  Pharmacy adherence measures to assess adherence to antiretroviral therapy: review of the literature and implications for treatment monitoring. , 2011, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[8]  M. Sprangers,et al.  Self-reported adherence is more predictive of virological treatment response among patients with a lower tendency towards socially desirable responding , 2010, Antiviral therapy.

[9]  Wayne T. Steward,et al.  Developing useful highly active antiretroviral therapy adherence measures for India: the Prerana study. , 2010, Journal of acquired immune deficiency syndromes.

[10]  J. Nachega,et al.  Antiretroviral therapy adherence and retention in care in middle-income and low-income countries: current status of knowledge and research priorities , 2010, Current opinion in HIV and AIDS.

[11]  B. Chi,et al.  Adherence to first-line antiretroviral therapy affects non-virologic outcomes among patients on treatment for more than 12 months in Lusaka, Zambia , 2009, International journal of epidemiology.

[12]  S. Kaaya,et al.  Explaining Adherence Success in Sub-Saharan Africa: An Ethnographic Study , 2009, PLoS medicine.

[13]  R. Shafer,et al.  Rational use of antiretroviral therapy in low-income and middle-income countries: optimizing regimen sequencing and switching , 2008, AIDS.

[14]  P. Mee,et al.  Evaluation of the WHO criteria for antiretroviral treatment failure among adults in South Africa , 2008, AIDS.

[15]  J. Nachega,et al.  Pharmacy Refill Adherence Compared with CD4 Count Changes for Monitoring HIV-Infected Adults on Antiretroviral Therapy , 2008, PLoS medicine.

[16]  David R Bangsberg,et al.  Preventing HIV antiretroviral resistance through better monitoring of treatment adherence. , 2008, The Journal of infectious diseases.

[17]  D. Bennett,et al.  The World Health Organization's global strategy for prevention and assessment of HIV drug resistance , 2008, Antiviral therapy.

[18]  D. Bennett,et al.  World Health Organization surveys to monitor HIV drug resistance prevention and associated factors in sentinel antiretroviral treatment sites , 2008, Antiviral therapy.

[19]  R. Chaiwarith,et al.  Sensitivity and specificity of using CD4+ measurement and clinical evaluation to determine antiretroviral treatment failure in Thailand. , 2007, International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases.

[20]  D. G. Saple,et al.  Adherence to antiretroviral therapy and virologic suppression among HIV-infected persons receiving care in private clinics in Mumbai, India. , 2007, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[21]  R. Chaisson,et al.  Adherence to Nonnucleoside Reverse Transcriptase InhibitorBased HIV Therapy and Virologic Outcomes , 2007, Annals of Internal Medicine.

[22]  David R Bangsberg,et al.  Less than 95% adherence to nonnucleoside reverse-transcriptase inhibitor therapy can lead to viral suppression. , 2006, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[23]  Saad B Omer,et al.  Adherence to Highly Active Antiretroviral Therapy Assessed by Pharmacy Claims Predicts Survival in HIV-Infected South African Adults , 2006, Journal of acquired immune deficiency syndromes.

[24]  G. Guyatt,et al.  Adherence to antiretroviral therapy in sub-Saharan Africa and North America: a meta-analysis. , 2006, JAMA.

[25]  K. Mayer,et al.  Barriers and facilitators to antiretroviral medication adherence among patients with HIV in Chennai, India: a qualitative study. , 2005, AIDS patient care and STDs.

[26]  F. Oort,et al.  Self-Reported Adherence to Antiretroviral Therapy for HIV-1 Infection and Virologic Treatment Response: A Meta-Analysis , 2005, Journal of acquired immune deficiency syndromes.

[27]  Tara L. Kieffer,et al.  Intermittent HIV-1 viremia (Blips) and drug resistance in patients receiving HAART. , 2005, JAMA.

[28]  P. Harrigan,et al.  Predictors of HIV drug-resistance mutations in a large antiretroviral-naive cohort initiating triple antiretroviral therapy. , 2005, The Journal of infectious diseases.

[29]  D. Bangsberg,et al.  Measuring Adherence to Antiretroviral Therapy in a Diverse Population Using a Visual Analogue Scale , 2004, HIV clinical trials.

[30]  Marilyn M. Wagener,et al.  Adherence to protease inhibitor therapy and outcomes in patients with HIV infection (vol 133, pg 21, 2000) , 2002 .

[31]  Susan Swindells,et al.  Adherence to Protease Inhibitor Therapy and Outcomes in Patients with HIV Infection , 2000, Annals of Internal Medicine.

[32]  A. Wu,et al.  Self-reported adherence to antiretroviral medications among participants in HIV clinical trials: The AACTG Adherence Instruments , 2000, AIDS care.

[33]  Iit Jodhpur,et al.  Annual Report 2011-12 , 2012 .

[34]  R. Garg,et al.  Adherence to antiretroviral therapy & its determinants amongst HIV patients in India. , 2008, The Indian journal of medical research.

[35]  D. Bennett,et al.  Darunavir: pharmacokinetics and drug interactions. , 2008 .

[36]  A. Wanchu,et al.  Adherence to generic reverse transcriptase inhibitor-based antiretroviral medication at a Tertiary Center in North India , 2006, AIDS and Behavior.